医学
磁共振成像
优势比
置信区间
磁化率加权成像
回顾性队列研究
数字减影血管造影
血管炎
病理
放射科
队列
磁共振血管造影
流体衰减反转恢复
中枢神经系统
微血管病
神经组阅片室
神经学
神经影像学
队列研究
内科学
病理生理学
血管造影
病历
年轻人
计算机断层血管造影
小脑
作者
Prachi Mohapatra,Ayush Agarwal,Venugopalan Y. Vishnu,Divyani Garg,M. V. Padma Srivastava,Divya Madathiparambil Radhakrishnan,Awadh Kishor Pandit,Manjari Agarwal,Rohit Bhatia,Roopa Rajan,Anu Gupta,Mamta Bhusan Singh,Mehar Chand Sharma,Vaishali S. Suri,Sanaullah Mudassir,Achal Kumar Srivastava,Leve Joseph Devarajan Sebastian,Shailesh B Gaikwad,Ajay Kumar Garg
标识
DOI:10.3389/fimmu.2026.1961925
摘要
Background Primary central nervous system vasculitis (PCNSV) is a rare inflammatory vasculopathy with diverse clinical and radiological manifestations that often delay diagnosis. Although abnormalities on magnetic resonance imaging (MRI), including susceptibility-weighted imaging (SWI), fluid-attenuated inversion recovery (FLAIR), and contrast-enhanced imaging, are increasingly recognized, a characteristic imaging pattern that may facilitate diagnosis has not yet been described. We aimed to evaluate cerebellar tonsillar hemorrhages (CTH) as a potential imaging marker of PCNSV. Methods We conducted a retrospective observational study at a tertiary neuroscience referral center in India. The discovery cohort included 51 patients with biopsy-proven PCNSV and 44 hypertensive microangiopathy controls who underwent MRI between 2018 and 2024. The imaging findings were independently reviewed for CTH and associated enhancement patterns. The reproducibility of this imaging pattern was subsequently assessed in an independent replication cohort of 55 patients with digital subtraction angiography (DSA)-proven PCNSV, evaluated between 2018 and 2026. Results CTH were identified in 35/51 (68.6%) biopsy-proven PCNSV patients compared with 9/44 (20.4%) hypertensive controls (p<0.001). In the biopsy-proven discovery cohort, CTH demonstrated a sensitivity of 68.6% (95% confidence interval [CI], 54.1–80.9%) and specificity of 79.5% (95% CI, 64.7–90.2%) for distinguishing PCNSV from hypertensive microangiopathy and remained associated with PCNSV after adjustment for age and sex (adjusted odds ratio [OR] 12.52, 95% CI 3.46–56.94). This association persisted in exploratory age-restricted sensitivity analyses. Associated punctate or linear contrast enhancement was present in 33/35 (94.3%) CTH-positive biopsy-proven patients and was not observed in hypertensive controls with available contrast-enhanced MRI (0/4). In the independent DSA-proven replication cohort, CTH were observed in 41/55 (74.5%) patients, of whom 23/39 (58.9%) demonstrated associated cerebellar tonsillar enhancement on contrast-enhanced MRI. Interobserver agreement for CTH detection was high in the combined discovery cohort (Cohen’s κ = 0.94) and the DSA-proven replication cohort (κ = 0.91). CTH frequently occurred in the absence of clinical ataxia or diffuse brainstem involvement. Conclusion CTH represent a frequent and reproducible imaging finding in both biopsy-proven and DSA-proven PCNSV. The presence of CTH, particularly when accompanied by punctate or linear enhancement, may improve the radiological suspicion of PCNSV and help distinguish inflammatory microangiopathy from hypertensive small-vessel disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI